| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
5
4
4
2
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
A-
(Buy)
|
Fund Holdings
The fund is overweight to the financial sector.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 1.37 | 1.37 |
| Stocks | 87.68 | 87.68 |
| Bonds | 0.0 | 0.0 |
| Other | 1.5 | 1.5 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 7.73 | 7.73 |
| Convertible | 0.81 | 0.81 |
| Preferred | 0.91 | 0.91 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Marathon Oil Corp | MRO | 4.57 | 3.09 |
| Eli Lilly and Company | LLY | 10.97 | 2.8 |
| JPMorgan Chase & Co | JPM | 10.55 | 2.54 |
| Citigroup Inc | C | 15.98 | 2.46 |
| Comcast Corp | CMCSK | 11.29 | 2.42 |
| Marathon Petroleum Corp | MPC | 17.17 | 2.35 |
| Royal Dutch Shell PLC ADR Class A | RDS.A | -0.77 | 2.23 |
| Northrop Grumman Corp | NOC | 12.76 | 2.2 |
| Johnson & Johnson | JNJ | 21.03 | 2.2 |
| Baxter International Inc. | BAX | 4.05 | 2.13 |
